{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:00:41Z","timestamp":1791316841944,"version":"4.3.1"},"reference-count":190,"publisher":"Elsevier","isbn-type":[{"value":"9780128241431","type":"print"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/bs.pmbts.2020.11.001","type":"book-chapter","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T07:46:56Z","timestamp":1608104816000},"page":"175-202","source":"Crossref","is-referenced-by-count":40,"title":["Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.pmbts.2020.11.001_bb0010","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/mds.26624","article-title":"Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases","volume":"31","author":"Forloni","year":"2016","journal-title":"Mov Disord"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0015","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0020","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13195-014-0073-2","article-title":"Alpha-synuclein biology in Lewy body diseases","volume":"6","author":"Kim","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0030","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fnins.2019.00381","article-title":"The roles of post-translational modifications on alpha-synuclein in the pathogenesis of Parkinson's Diseases","volume":"13","author":"Zhang","year":"2019","journal-title":"Front Neurosci"},{"issue":"21","key":"10.1016\/bs.pmbts.2020.11.001_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218043","article-title":"Multiplicity of \u03b1-synuclein aggregated species and their possible roles in disease","volume":"21","author":"Gracia","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"suppl 1","key":"10.1016\/bs.pmbts.2020.11.001_bb0040","article-title":"\u03b1-Synucleinopathy phenotypes","volume":"20","author":"McCann","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuroscience.2014.10.028","article-title":"Inflammation is genetically implicated in Parkinson's disease","volume":"302","author":"Dzamko","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","article-title":"Parkinson disease and the immune system\u2014associations, mechanisms and therapeutics","volume":"16","author":"Tan","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0055","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1289\/ehp.1003013","article-title":"Neuroinflammation and \u03b1-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease","volume":"119","author":"Gao","year":"2011","journal-title":"Environ Health Perspect"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0060","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1212\/WNL.0b013e31820f2d79","article-title":"Use of ibuprofen and risk of Parkinson disease","volume":"76","author":"Gao","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0065","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.bbi.2018.02.012","article-title":"Alpha-synuclein oligomers impair memory through glial cell activation and via toll-like receptor 2","volume":"69","author":"La Vitola","year":"2018","journal-title":"Brain Behav Immun"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0070","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s12035-012-8267-8","article-title":"Inflammation and \u03b1-synuclein's prion-like behavior in Parkinson's disease\u2014is there a link?","volume":"47","author":"Lema-Tom\u00e9","year":"2013","journal-title":"Mol Neurobiol"},{"issue":"7660","key":"10.1016\/bs.pmbts.2020.11.001_bb0075","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson's disease recognize \u03b1-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3389\/fnins.2020.00443","article-title":"LRRK2 at the interface between peripheral and central immune function in Parkinson's","volume":"14","author":"Wallings","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0085","series-title":"Hundbuch der Neurologie III","first-page":"920","article-title":"Paralysis agitans. I. Pathologische Anatomie","author":"Lewy","year":"1912"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0090","doi-asserted-by":"crossref","DOI":"10.1111\/neup.12691","article-title":"Where and how alpha-synuclein pathology spreads in Parkinson's disease","author":"Wakabayashi","year":"2020","journal-title":"Neuropathology"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0095","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0100","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0105","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"10.1016\/bs.pmbts.2020.11.001_bb0110","doi-asserted-by":"crossref","first-page":"7332","DOI":"10.3390\/ijms21197332","article-title":"Genetic risk profiling in Parkinson's disease and utilizing genetics to gain insight into disease-related biological pathways","volume":"21","author":"Hall","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"suppl 1","key":"10.1016\/bs.pmbts.2020.11.001_bb0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jnc.13593","article-title":"Genetics in Parkinson disease: mendelian versus non-mendelian inheritance","volume":"139","author":"Hernandez","year":"2016","journal-title":"J Neurochem"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0120","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"\u03b1-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat Cell Biol"},{"issue":"6","key":"10.1016\/bs.pmbts.2020.11.001_bb0125","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/jnen\/62.6.644","article-title":"Accumulation of phosphorylated alpha-synuclein in aging human brain","volume":"62","author":"Saito","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0130","doi-asserted-by":"crossref","first-page":"20305","DOI":"10.1073\/pnas.1922741117","article-title":"Parkinson's disease-related phosphorylation at Tyr39 rearranges alpha-synuclein amyloid fibril structure revealed by cryo-EM","volume":"117","author":"Zhao","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0135","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00005072-196507000-00003","article-title":"Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus caeruleus in Parkinson's disease","volume":"24","author":"Duffy","year":"1965","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00688674","article-title":"Ultrastructure of Lewy bodies in the stellate ganglion","volume":"34","author":"Forno","year":"1976","journal-title":"Acta Neuropathol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0145","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36402","article-title":"Cryo-EM structure of alpha-synuclein fibrils","volume":"7","author":"Guerrero-Ferreira","year":"2018","journal-title":"Elife"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0150","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","article-title":"Structures of \u03b1-synuclein filaments from multiple system atrophy","volume":"585","author":"Schweighauser","year":"2020","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0155","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0160","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/jnen\/nlz080","article-title":"Unified staging system for Lewy body disorders: clinicopathologic correlations and comparison to braak staging","volume":"78","author":"Adler","year":"2019","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0165","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00702-018-1898-9","article-title":"Is Braak staging valid for all types of Parkinson's disease?","volume":"126","author":"Jellinger","year":"2019","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0170","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic alpha synuclein from the gut to the brain models Parkinson's disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0175","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3940(00)01623-2","article-title":"Pure autonomic failure in association with human alpha-synucleinopathy","volume":"296","author":"Arai","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0180","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1474-4422(13)70056-5","article-title":"Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study","volume":"12","author":"Iranzo","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0185","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1212\/WNL.56.7.980","article-title":"Accumulation of alpha-synuclein in autonomic nerves in pure autonomic failure","volume":"56","author":"Kaufmann","year":"2001","journal-title":"Neurology"},{"issue":"pt B","key":"10.1016\/bs.pmbts.2020.11.001_bb0190","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.nbd.2017.03.007","article-title":"Internalization, axonal transport and release of fibrillar forms of alpha-synuclein","volume":"109","author":"Bieri","year":"2018","journal-title":"Neurobiol Dis"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0195","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","article-title":"Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats","volume":"128","author":"Holmqvist","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13024-018-0257-5","article-title":"Inoculation of alpha-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve","volume":"13","author":"Uemura","year":"2018","journal-title":"Mol Neurodegener"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0205","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","article-title":"The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system","volume":"14","author":"Iwai","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0210","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","article-title":"Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease","volume":"90","author":"U\u00e9da","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0215","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.bpj.2010.06.035","article-title":"The N-terminus of the intrinsically disordered protein alpha-synuclein triggers membrane binding and helix folding","volume":"99","author":"Bartels","year":"2010","journal-title":"Biophys J"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0220","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0225","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","article-title":"Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils","volume":"322","author":"Lashuel","year":"2002","journal-title":"J Mol Biol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0230","doi-asserted-by":"crossref","first-page":"C862","DOI":"10.1152\/ajpcell.00077.2003","article-title":"Channels formed with a mutant prion protein PrP(82-146) homologous to a 7-kDa fragment in diseased brain of GSS patients","volume":"285","author":"Bahadi","year":"2003","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0235","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic A\u03b2 oligomer and Alzheimer's disease: an emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0240","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","article-title":"Different species of alpha-synuclein oligomers induce calcium influx and seeding","volume":"27","author":"Danzer","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0245","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s12035-012-8331-4","article-title":"Subramaniam V alpha-synuclein oligomers: an amyloid pore? Insights into mechanisms of alpha-synuclein oligomer-lipid interactions","volume":"47","author":"St\u00f6ckl","year":"2013","journal-title":"Mol Neurobiol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0250","first-page":"E1994","article-title":"Structural characterization of toxic oligomers that are kinetically trapped during \u03b1-synuclein fibril formation","volume":"112","author":"Chen","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0255","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/brain\/awu057","article-title":"Accumulation of oligomer-prone a-synuclein exacerbates synaptic and neuronal degeneration in vivo","volume":"137","author":"Rockenstein","year":"2014","journal-title":"Brain"},{"issue":"Pt B","key":"10.1016\/bs.pmbts.2020.11.001_bb0260","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.nbd.2017.07.009","article-title":"The contribution of biophysical and structural studies of protein self-assembly to the design of therapeutic strategies for amyloid diseases","volume":"109","author":"Cremades","year":"2018","journal-title":"Neurobiol Dis"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0265","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","article-title":"Direct observation of the interconversion of normal and toxic forms of \u03b1-synuclein","volume":"149","author":"Cremades","year":"2012","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0270","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/bs.ircmb.2016.08.010","article-title":"Structural characteristics of \u03b1-synuclein oligomers","volume":"329","author":"Cremades","year":"2017","journal-title":"Int Rev Cell Mol Biol"},{"issue":"Pt B","key":"10.1016\/bs.pmbts.2020.11.001_bb0275","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.brainres.2015.06.002","article-title":"Post-translational modification of \u03b1-synuclein in Parkinson's disease","volume":"1628","author":"Barrett","year":"2015","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/bs.pmbts.2020.11.001_bb0280","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/s41598-018-38271-2","article-title":"Early stage alpha-synuclein amyloid fibrils are reservoirs of membrane-binding species","volume":"9","author":"Skamris","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0285","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s42003-019-0598-9","article-title":"Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson's disease","volume":"2","author":"de Oliveira","year":"2019","journal-title":"Commun Biol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0290","doi-asserted-by":"crossref","first-page":"10392","DOI":"10.1074\/jbc.RA119.007743","article-title":"Defining \u03b1-synuclein species responsible for Parkinson's disease phenotypes in mice","volume":"294","author":"Froula","year":"2019","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/bs.pmbts.2020.11.001_bb0295","doi-asserted-by":"crossref","first-page":"E1206","DOI":"10.1073\/pnas.1524128113","article-title":"Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading","volume":"113","author":"Iljina","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/bs.pmbts.2020.11.001_bb0300","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jnc.14808","article-title":"\u03b1-Synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities","volume":"150","author":"Alam","year":"2019","journal-title":"J Neurochem"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0305","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00401-017-1755-1","article-title":"Alpha-synuclein oligomers: a new hope","volume":"134","author":"Bengoa-Vergniory","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb906","doi-asserted-by":"crossref","first-page":"7813","DOI":"10.1073\/pnas.1713129115","article-title":"\u03b1-Synucleinoligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies","volume":"115","author":"Prots","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0310","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0092-8674(93)90635-4","article-title":"Seeding \u201cone-dimensional crystallization\u201d of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?","volume":"73","author":"Jarrett","year":"1993","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0315","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1073\/pnas.90.13.5959","article-title":"A kinetic model for amyloid formation in the prion diseases: importance of seeding","volume":"90","author":"Come","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0320","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/1074-5521(95)90071-3","article-title":"The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease?","volume":"2","author":"Han","year":"1995","journal-title":"Chem Biol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0325","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3940(00)01153-8","article-title":"Full length alpha- synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects","volume":"287","author":"Borghi","year":"2000","journal-title":"Neurosci Lett"},{"issue":"suppl 3","key":"10.1016\/bs.pmbts.2020.11.001_bb0330","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1016\/S1353-8020(09)70802-8","article-title":"Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson's disease","volume":"15","author":"Angot","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0335","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrn2477","article-title":"Research in motion: the enigma of Parkinson's disease pathology spread","volume":"9","author":"Brundin","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0340","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0345","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0350","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nm1752","article-title":"Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years","volume":"14","author":"Mendez","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0355","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tins.2010.04.003","article-title":"The propagation of prion-like protein inclusions in neurodegenerative diseases","volume":"33","author":"Goedert","year":"2010","journal-title":"Trends Neurosci"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0360","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41593-018-0238-6","article-title":"Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases","volume":"21","author":"Juker","year":"2018","journal-title":"Nat Neurosci"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0365","doi-asserted-by":"crossref","first-page":"23815","DOI":"10.1073\/pnas.2007406117","article-title":"Highly infectious prions are not directly neurotoxic","volume":"117","author":"Benilova","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0370","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature09768","article-title":"Prion propagation and toxicity in vivo occur in two distinct mechanistic phasess","volume":"470","author":"Sandberg","year":"2011","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0375","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1096\/fj.03-0098fje","article-title":"Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma","volume":"17","author":"El-Agnaf","year":"2003","journal-title":"Faseb J"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0380","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00702-005-0427-9","article-title":"The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy","volume":"113","author":"Lee","year":"2006","journal-title":"J Neural Transm (Vienna)"},{"issue":"5","key":"10.1016\/bs.pmbts.2020.11.001_bb0385","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10072-019-03738-1","article-title":"Plasma alpha-synuclein levels in patients with Parkinson's disease: a systematic review and meta-analysis","volume":"40","author":"Bougea","year":"2019","journal-title":"Neurol Sci"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0390","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41582-020-0349-z","article-title":"Exosomal \u03b1-synuclein as a biomarker for Parkinson disease","volume":"16","author":"Lempri\u00e8re","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"10.1016\/bs.pmbts.2020.11.001_bb0395","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and blood biomarkers for Parkinson's disease","volume":"18","author":"Parnetti","year":"2019","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/bs.pmbts.2020.11.001_bb0400","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/brain\/awaa090","article-title":"Microglial exosomes facilitate \u03b1-synuclein transmission in Parkinson's disease","volume":"143","author":"Guo","year":"2020","journal-title":"Brain"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0405","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40478-017-0445-5","article-title":"Brain-derived exosomes from dementia with Lewy bodies propagate \u03b1-synuclein pathology","volume":"5","author":"Ngolab","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0410","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1073\/pnas.0911829107","article-title":"Synthetic amyloid-\u03b2 oligomers impair memory independently of cellular prion protein","volume":"107","author":"Balducci","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0415","first-page":"32","article-title":"Extracellular alpha synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation","volume":"22","author":"Diogenes","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0420","doi-asserted-by":"crossref","first-page":"E4648","DOI":"10.1073\/pnas.1704698114","article-title":"Selective lowering of synapsins induced by oligomeric alpha-synuclein exacerbates memory deficits","volume":"114","author":"Larson","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0425","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.2174\/13816128113199990497","article-title":"In vivo application of beta amyloid oligomers: a simple tool to evaluate mechanisms of action and new therapeutic approaches","volume":"20","author":"Balducci","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0430","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3233\/JPD-171103","article-title":"The role of lipids interacting with alpha-synuclein in the pathogenesis of Parkinson's disease","volume":"7","author":"Galvagnion","year":"2017","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0435","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4103\/1673-5374.235013","article-title":"Subcellular localization of alpha-synuclein aggregates and their interaction with membranes","volume":"13","author":"Miraglia","year":"2018","journal-title":"Neural Regen Res"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0440","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.aan6160","article-title":"Structural basis of membrane disruption and cellular toxicity by alpha-synuclein oligomers","volume":"358","author":"Fusco","year":"2017","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0445","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.febslet.2013.12.015","article-title":"The N-terminus of alpha-synuclein is essential for both monomeric and oligomeric interactions with membranes","volume":"588","author":"Lorenzen","year":"2014","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/bs.pmbts.2020.11.001_bb0450","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41467-018-04422-2","article-title":"\u03b1-Synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease","volume":"9","author":"Ludtmann","year":"2018","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/bs.pmbts.2020.11.001_bb0455","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/nn.4648","article-title":"\u03b1-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B","volume":"20","author":"Ferreira","year":"2017","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.11.001_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116473","article-title":"Identification of synaptosomal proteins binding to monomeric and oligomeric alpha-synuclein","volume":"10","author":"Betzer","year":"2015","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/bs.pmbts.2020.11.001_bb0465","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1002\/anie.201914878","article-title":"The molecular basis of the interaction of cyclophilin a with \u03b1-synuclein","volume":"59","author":"Favretto","year":"2020","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0470","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13024-015-0062-3","article-title":"Alpha-synuclein interacts with SOD1 and promotes its oligomerization","volume":"10","author":"Helferich","year":"2015","journal-title":"Mol Neurodegener"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0475","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00401-019-02007-x","article-title":"Acta binding of alpha-synuclein oligomers to Cx32 facilitates protein uptake and transfer in neurons and oligodendrocytes","volume":"138","author":"Reyes","year":"2019","journal-title":"Neuropathology"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0480","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/acschemneuro.8b00407","article-title":"Interaction of alpha-synuclein with ATP synthase: switching role from physiological to pathological","volume":"10","author":"Tripathi","year":"2019","journal-title":"ACS Chem Nerosci"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0485","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/brain\/awy318","article-title":"Cellular prion protein neither binds to alpha-synuclein oligomers nor mediates their detrimental effects","volume":"142","author":"La Vitola","year":"2019","journal-title":"Brain"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0490","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","article-title":"Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers","volume":"457","author":"Lauren","year":"2009","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0495","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4161\/pri.5.1.14367","article-title":"\u03b2-Amyloid oligomers and prion protein: fatal attraction?","volume":"5","author":"Forloni","year":"2011","journal-title":"Prion"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0500","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.biopsych.2017.11.020","article-title":"Prion protein as a toxic acceptor of amyloid-\u03b2 oligomers","volume":"83","author":"Purro","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0505","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00401-019-02114-9","article-title":"PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins","volume":"139","author":"Corbett","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0510","doi-asserted-by":"crossref","first-page":"7857","DOI":"10.1074\/jbc.M112.423954","article-title":"An N-terminal fragment of the prion protein binds to amyloid-\u03b2 oligomers and inhibits their neurotoxicity in vivo","volume":"288","author":"Fluharty","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0515","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.3389\/fimmu.2019.02780","article-title":"Heterozygous CX3CR1 deficiency in microglia restores neuronal \u03b2-amyloid clearance pathways and slows progression of Alzheimer's like-disease in PS1-APP mice","volume":"10","author":"Hickman","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0520","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1210\/endo.136.3.7867598","article-title":"Central endotoxin induces different patterns of interleukin (IL)-1 beta and IL-6 messenger ribonucleic acid expression and IL-6 secretion in the brain and periphery","volume":"136","author":"De Simoni","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0525","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4103\/1673-5374.293134","article-title":"Regulation of neuroimmune processes by damage- and resolution-associated molecular patterns","volume":"16","author":"Klegeris","year":"2021","journal-title":"Neural Regen Res"},{"issue":"1","key":"10.1016\/bs.pmbts.2020.11.001_bb0530","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/embj.201386609","article-title":"The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus","volume":"33","author":"Schwartz","year":"2014","journal-title":"Embo J"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0535","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1038\/s41467-019-11928-w","article-title":"Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease","volume":"10","author":"Krashia","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0540","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/glia.22372","article-title":"Microglia as modulators of cognition and neuropsychiatric disorders","volume":"61","author":"Blank","year":"2013","journal-title":"Glia"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0545","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3233\/JAD-161123","article-title":"Dynamics of the complement, cytokine, and chemokine systems in the regulation of synaptic function and dysfunction relevant to Alzheimer's disease","volume":"57","author":"Jiang","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0550","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"issue":"6478","key":"10.1016\/bs.pmbts.2020.11.001_bb0555","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.aaz2288","article-title":"Microglia mediate forgetting via complement-dependent synaptic elimination","volume":"367","author":"Wang","year":"2020","journal-title":"Science"},{"issue":"6","key":"10.1016\/bs.pmbts.2020.11.001_bb0560","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00401-011-0833-z","article-title":"Glial dysfunction in the pathogenesis of \u03b1-synucleinopathies: emerging concepts","volume":"121","author":"Fellner","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.11.001_bb0565","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s12035-012-8340-3","article-title":"The role of glia in \u03b1-synucleinopathies","volume":"47","author":"Fellner","year":"2013","journal-title":"Mol Neurobiol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0570","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fneur.2019.00122","article-title":"Inflammation, infectious triggers, and Parkinson's disease","volume":"10","author":"Caggiu","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0575","doi-asserted-by":"crossref","first-page":"308654","DOI":"10.1155\/2014\/308654","article-title":"Evidence of inflammatory system involvement in Parkinson's disease","volume":"2014","author":"Chao","year":"2014","journal-title":"Biomed Res Int"},{"issue":"10","key":"10.1016\/bs.pmbts.2020.11.001_bb0580","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/acn3.50877","article-title":"11 C-PK11195 PET imaging and white matter changes in Parkinson's disease dementia","volume":"6","author":"Nicastro","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0585","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/bs.irn.2018.08.009","article-title":"Molecular imaging of neuroinflammation in idiopathic Parkinson's disease","volume":"141","author":"Roussakis","year":"2018","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0590","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.arr.2017.12.007","article-title":"The genetics of Parkinson disease","volume":"42","author":"Deng","year":"2018","journal-title":"Ageing Res Rev"},{"issue":"8","key":"10.1016\/bs.pmbts.2020.11.001_bb0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002237","article-title":"Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee","volume":"7","author":"Hamza","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0600","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/cge.12024","article-title":"Association of HLA locus variant in Parkinson's disease","volume":"84","author":"Zhao","year":"2013","journal-title":"Clin Genet"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0605","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/mds.27659","article-title":"International Parkinson's Disease Genomics Consortium (IPDGC). Parkinson's disease age at onset genome-wide association study: defining heritability, genetic loci, and \u03b1-synuclein mechanisms","volume":"34","author":"Blauwendraat","year":"2019","journal-title":"Mov Disord"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0610","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nrneurol.2012.148","article-title":"Whole-genome and whole-exome sequencing in neurological diseases","volume":"8","author":"Foo","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0615","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/mds.27001","article-title":"Tau\/\u03b1-synuclein ratio and inflammatory proteins in Parkinson's disease: an exploratory study","volume":"32","author":"Delgado-Alvarado","year":"2017","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/bs.pmbts.2020.11.001_bb0620","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3233\/JPD-191699","article-title":"Plasma IL-6 and IL-17A correlate with severity of motor and non-motor symptoms in Parkinson's disease","volume":"9","author":"Green","year":"2019","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0625","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neulet.2018.07.027","article-title":"Association of Parkinson's disease-related pain with plasma interleukin-1, interleukin-6, interleukin-10, and tumour necrosis factor-\u03b1","volume":"683","author":"Li","year":"2018","journal-title":"Neurosci Lett"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0630","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3389\/fneur.2018.01081","article-title":"Immune cell activation in the cerebrospinal fluid of patients with Parkinson's disease","volume":"9","author":"Schr\u00f6der","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0635","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jocn.2020.04.058","article-title":"Plasma cytokine profile in synucleinophaties with dementia","volume":"78","author":"Usenko","year":"2020","journal-title":"J Clin Neurosci"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0640","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nbd.2006.06.013","article-title":"Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra","volume":"24","author":"Ferrari","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb907","doi-asserted-by":"crossref","first-page":"13322","DOI":"10.1021\/bi7014053","article-title":"Role of different regions of alpha-synucleinin the assembly of fibrils","volume":"46","author":"Qin","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0645","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mds.23455","article-title":"Glia: initiators and progressors of pathology in Parkinson's disease","volume":"26","author":"Halliday","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0650","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.nlm.2013.07.002","article-title":"Microglia: a new frontier for synaptic plasticity, learning and memory, and neurodegenerative disease research","volume":"105","author":"Morris","year":"2013","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0655","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3233\/JAD-170819","article-title":"Alzheimer's disease, oligomers, and inflammation","volume":"62","author":"Forloni","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb908","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbi.2016.10.012","article-title":"Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by \u03b2-amyloid oligomers in an acute mouse model of Alzheimer's disease","volume":"60","author":"Balducci","year":"2017","journal-title":"Brain Behav Immun"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0660","article-title":"Peripheral inflammation exacerbates \u03b1-synuclein toxicity and neuropathology in Parkinson's models","author":"La Vitola","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"suppl 1","key":"10.1016\/bs.pmbts.2020.11.001_bb0665","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.parkreldis.2017.07.033","article-title":"Neuropathology of Parkinson disease","volume":"46","author":"Dickson","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0670","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.55.1.132","article-title":"Activated microglia in dementia with Lewy bodies","volume":"55","author":"Mackenzie","year":"2000","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.pmbts.2020.11.001_bb0675","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinson's disease","volume":"23","author":"McGeer","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0680","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neures.2010.12.020","article-title":"Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line","volume":"69","author":"Alvarez-Erviti","year":"2011","journal-title":"Neurosci Res"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0685","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0690","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pneurobio.2018.06.010","article-title":"Non-cell-autonomous actions of \u03b1-synuclein: implications in glial synucleinopathies","volume":"169","author":"Lim","year":"2018","journal-title":"Prog Neurobiol"},{"issue":"7","key":"10.1016\/bs.pmbts.2020.11.001_bb0695","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.94","article-title":"Alpha synclein from secretion to dysfucntion and death","volume":"3","author":"Marques","year":"2012","journal-title":"Cell Death Dis"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0700","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-019-01977-2","article-title":"\u03b1-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease","volume":"138","author":"Sorrentino","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0705","doi-asserted-by":"crossref","first-page":"1859431","DOI":"10.1155\/2020\/1859431","article-title":"Role of astrocytic dysfunction in the pathogenesis of Parkinson's disease animal models from a molecular signaling perspective","volume":"2020","author":"Udovin","year":"2020","journal-title":"Neural Plast"},{"issue":"45","key":"10.1016\/bs.pmbts.2020.11.001_bb0710","doi-asserted-by":"crossref","first-page":"8618","DOI":"10.1523\/JNEUROSCI.0954-20.2020","article-title":"Astrocytes protect human dopaminergic neurons from \u03b1-synuclein accumulation and propagation","volume":"40","author":"Tsunemi","year":"2020","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/bs.pmbts.2020.11.001_bb0715","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.celrep.2017.12.092","article-title":"Cellular senescence is induced by the environmental neurotoxin paraquat and contributes to neuropathology linked to Parkinson's disease","volume":"22","author":"Chinta","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0720","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12974-018-1302-6","article-title":"\u03b1-Synuclein disrupts the anti-inflammatory role of Drd2 via interfering \u03b2-arrestin2-TAB1 interaction in astrocytes","volume":"15","author":"Du","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0725","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/glia.23258","article-title":"Parkinson's disease gene, DJ-1, repairs brain injury through Sox9 stabilization and astrogliosis","volume":"66","author":"Choi","year":"2018","journal-title":"Glia"},{"issue":"9","key":"10.1016\/bs.pmbts.2020.11.001_bb0730","article-title":"Extracellular alpha-synuclein promotes a neuroinhibitory secretory phenotype in astrocytes","volume":"10","author":"Di Marco","year":"2020","journal-title":"Life"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0735","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/mds.27994","article-title":"Lysosome and inflammatory defects in GBA1-mutant astrocytes are normalized by LRRK2 inhibition","volume":"35","author":"Sanyal","year":"2020","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/bs.pmbts.2020.11.001_bb0740","doi-asserted-by":"crossref","first-page":"14474","DOI":"10.1038\/s41598-020-71329-8","article-title":"Metabolic alterations in Parkinson's disease astrocytes","volume":"10","author":"Sonninen","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0745","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2017.04.019","article-title":"Gut microbiota in Parkinson disease in a northern German cohort","volume":"1667","author":"Hopfner","year":"2017","journal-title":"Brain Res"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0750","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/mds.26307","article-title":"Colonic bacterial composition in Parkinson's disease: colonic microbiota in Parkinson's disease","volume":"30","author":"Keshavarzian","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0755","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson's disease and clinical phenotype: gut microbiota in Parkinson's disease","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0760","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","article-title":"Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls","volume":"32","author":"Unger","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0765","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","article-title":"Multi-organ distribution of phosphorylated \u03b1-synuclein histopathology in subjects with Lewy body disorders","volume":"119","author":"Arizona Parkinson's Disease Consortium","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0770","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric \u03b1-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0775","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF00294234","article-title":"Parkinson's disease: an immunohisto-chemical study of Lewy body-containing neurons in the enteric nervous system","volume":"79","author":"Wakabayashi","year":"1990","journal-title":"Acta Neuropathol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb909","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0780","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-019-1405-y","article-title":"Intestinal infection triggers Parkinson's disease-like symptoms in Pink1\u2212\/\u2212 mice","volume":"571","author":"Matheoud","year":"2019","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0790","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41374-019-0195-z","article-title":"Transmission of \u03b1-synuclein seeds in neurodegenerative disease: recent developments","volume":"99","author":"Karpowicz","year":"2019","journal-title":"Lab Invest"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0795","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological -synuclein transmission initiates parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0800","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/srep00898","article-title":"Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice","volume":"2","author":"Pan-Montojo","year":"2012","journal-title":"Sci Rep"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0805","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/emmm.201302475","article-title":"Caudo-rostral brain spreading of \u03b1-synuclein through vagal connections","volume":"5","author":"Ulusoy","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0810","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40478-015-0198-y","article-title":"Neuron-to-neuron \u03b1-synuclein propagation in vivo is independent of neuronal injury","volume":"3","author":"Ulusoy","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb910","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.24448","article-title":"Vagotomyand subsequent risk of Parkinson's disease","volume":"78","author":"Svensson","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0815","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nbd.2018.01.008","article-title":"Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology","volume":"112","author":"Manfredsson","year":"2018","journal-title":"Neurobiol Dis"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb911","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/1874609810666170315113244","article-title":"Neuroinflammation as a common mechanism associated with the modifiable risk factors for Alzheimer's and Parkinson's diseases","volume":"10","author":"McKenzie","year":"2017","journal-title":"Curr Aging Sci"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0820","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbi.2019.06.042","article-title":"Toll-like receptors and their therapeutic potential in Parkinson's disease and \u03b1-synucleinopathies","volume":"81","author":"Kouli","year":"2019","journal-title":"Brain Behav Immun"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0825","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fnins.2011.00080","article-title":"\u03b1-Synuclein alters toll-like receptor expression","volume":"5","author":"B\u00e9raud","year":"2011","journal-title":"Front Neurosci"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb912","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.neurobiolaging.2007.08.018","article-title":"Screening of innate immune receptors in neurodegenerative diseases: a similar pattern","volume":"30","author":"Letiembre","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0830","first-page":"pyu103","article-title":"Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease","volume":"18","author":"Drouin-Ouellet","year":"2015","journal-title":"Int J Neuropharmacol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0835","first-page":"90","article-title":"Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients","volume":"2","author":"Doorn","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0840","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1038\/s41467-018-04569-y","article-title":"TLR9 activation via microglial glucocorticoid receptors contributes to degeneration of midbrain dopamine neurons","volume":"9","author":"Maatouk","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb913","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5607\/en.2016.25.3.113","article-title":"Non-cell-autonomous neurotoxicity of \u03b1-synuclein through microglial toll-like receptor 2","volume":"25","author":"Kim","year":"2016","journal-title":"Exp Neurobiol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0845","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13024-018-0276-2","article-title":"Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating \u03b1-synuclein transmission and neuroinflammation","volume":"13","author":"Kim","year":"2018","journal-title":"Mol Neurodegener"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb914","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb915","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12868-015-0192-0","article-title":"Exogenous alpha-synucleininduces toll-like receptor 4 dependent inflammatory responses in astrocytes","volume":"16","author":"Rannikko","year":"2015","journal-title":"BMC Neurosci"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0850","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/bs.pmbts.2020.11.001_bb0855","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00228-018-2561-y","article-title":"Non-steroidal anti-inflammatory drugs and risk of Parkinson's disease in the elderly population: a meta-analysis","volume":"75","author":"Poly","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0860","article-title":"Neuroinflammatory responses in Parkinson's disease: relevance of Ibuprofen in therapeutics","author":"Singh","year":"2020","journal-title":"Inflammopharmacology"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0865","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nrneurol.2016.196","article-title":"Precision medicine for disease modification in Parkinson disease","volume":"13","author":"Espay","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb916","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/jpet.118.252064","article-title":"Plasma and brain concentrations of doxycycline after single and repeated doses in wild-type and APP23 mice","volume":"368","author":"Lucchetti","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0870","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0014-5793(00)02380-2","article-title":"Anti-amyloidogenic activity of tetracyclines: studies in vitro","volume":"487","author":"Forloni","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0875","doi-asserted-by":"crossref","first-page":"10849","DOI":"10.1073\/pnas.162195499","article-title":"Tetracyclines affect prion infectivity","volume":"99","author":"Forloni","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0880","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neurobiolaging.2018.06.002","article-title":"Doxycycline counteracts neuroinflammation restoring memory in Alzheimer's disease mouse models","volume":"70","author":"Balducci","year":"2018","journal-title":"Neurobiol Aging"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0885","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3389\/fphar.2019.00738","article-title":"Doxycycline for Alzheimer's disease: fighting \u03b2-amyloid oligomers and neuroinflammation","volume":"10","author":"Balducci","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0890","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s12035-019-01847-8","article-title":"Neuroprotective effects of doxycycline in the R6\/2 mouse model of Huntington's disease","volume":"57","author":"Paldino","year":"2020","journal-title":"Mol Neurobiol"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0895","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/19336896.2015.1027857","article-title":"Preventive study in subjects at risk of fatal familial insomnia: innovative approach to rare diseases","volume":"9","author":"Forloni","year":"2015","journal-title":"Prion"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0900","doi-asserted-by":"crossref","first-page":"41755","DOI":"10.1038\/srep41755","article-title":"Repurposing doxycycline for synucleinopathies: remodelling of alpha-synuclein oligomers towards non-toxic parallel beta-sheet structured species","volume":"7","author":"Gonz\u00e1lez-Liz\u00e1rraga","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/bs.pmbts.2020.11.001_bb0905","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.expneurol.2019.04.013","article-title":"Roscovitine, an experimental CDK5 inhibitor, causes delayed suppression of microglial, but not astroglial recruitment around intracerebral dopaminergic grafts","volume":"318","author":"Tomov","year":"2019","journal-title":"Exp Neurol"}],"container-title":["Progress in Molecular Biology and Translational Science","Molecular Biology of Neurodegenerative Diseases: Visions for the Future, Part B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117320301708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117320301708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T04:01:33Z","timestamp":1761796893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117320301708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780128241431"],"references-count":190,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2020.11.001","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}